Farther Finance Advisors »

Calidi Biotherapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Calidi Biotherapeutics shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $12k 10k 1.17

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Calidi Biotherapeutics

HighTower Advisors
Vanguard Group
Geode Capital Management
Belpointe Asset Management
Warberg Asset Management
Rs Crum
Farther Finance Advisors
UBS Group
Highbridge Capital Management
Finepoint Capital
Apollo Management Holdings
Royal Bank of Canada
Barrett & Company
Advisor Group Holdings
FMR

View all funds holding Calidi Biotherapeutics